T1	Treatment 24 35	pramipexole
T2	Treatment 281 292	pramipexole
T3	Treatment 517 669	polysomnography, and patients self-assessed their sleep disturbance and overall RLS severity using the international RLS study group rating scale (IRLS)
T4	Treatment 671 742	Four pramipexole doses were evaluated: 0.125, 0.25, 0.50, and 0.75mg/d.
T5	Treatment 831 842	pramipexole
T6	Treatment 1029 1036	placebo
T7	Treatment 1253 1264	pramipexole
T8	Treatment 1450 1462	pramipexole.
T9	Treatment 1559 1566	placebo
T10	Treatment 1849 1860	pramipexole
T11	Treatment 1898 1906	placebo.
T12	Treatment 2059 2070	Pramipexole
